Tokyo, Aug. 31 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000062713) titled 'Gait changes in patients with hip osteoarthritis evaluated using an accelerometer' on Aug. 31.

Study Type: Interventional

Study Design: Basic Design - Single arm Randomization - Non-randomized Blinding - Open -no one is blinded Control - Uncontrolled

Primary Sponsor: Institute - Iwate Medical University

Condition: Condition - hip osteoarthritis Classification by malignancy - Others Genomic information - NO

Objective: Narrative objectives1 - By attaching an accelerometer to the trunk during a walking test, it is possible to capture changes in trunk posture and gait parameters associated with continued walking. The purpose of this study is to evaluate the characteristics of gait in patients with hip osteoarthritis by comparing them with healthy, ambulatory individuals. Basic objectives2 - Others

Intervention: Interventions/Control_1 - Subjects wearing accelerometers perform three Timed Up and Go (TUG) tests and one 6-minute walk test. This intervention is conducted only once.

Eligibility: Age-lower limit - 18 years-old <= Age-upper limit - Not applicable Gender - Male and Female Key inclusion criteria - Hip Osteoarthritis (OA) Group Patients meeting all of the following criteria: 1)Outpatients attending the Department of Orthopedic Surgery at Iwate Medical University Hospital or Morioka City Hospital. 2)Patients with hip osteoarthritis who have no active cardiovascular or respiratory diseases requiring treatment. 3)Patients with hip osteoarthritis who provided written informed consent after receiving a thorough explanation of this study. 4)Aged 18 years or older.

Control Group (Individuals without hip disease or gait impairment) Individuals meeting all of the following criteria: 1)Outpatients attending the Department of Orthopedic Surgery at Iwate Medical University Hospital or Morioka City Hospital who do not have hip disease. 2)Individuals without gait impairment and without active cardiovascular or respiratory diseases requiring treatment. 3)Individuals who provided written informed consent after receiving a thorough explanation of this study. 4)Aged 18 years or older. Key exclusion criteria - Hip Osteoarthritis (OA) Group 1)Patients who are unable to walk. 2)Patients with symptomatic spinal deformities associated with conditions such as parkinsonism or myasthenia gravis. 3)Patients deemed inappropriate for participation in this study by the investigators.

Control Group (Individuals without hip disease or gait impairment) 1)Individuals with symptomatic spinal deformities associated with conditions such as parkinsonism or myasthenia gravis. 2)Individuals deemed inappropriate for participation in this study by the investigators. Target Size - 40

Recruitment Status: Recruitment status - Completed Date of protocol fixation - 2022 Year 10 Month 31 Day Date of IRB - 2023 Year 01 Month 16 Day Anticipated trial start date - 2023 Year 02 Month 01 Day Last follow-up date - 2024 Year 03 Month 31 Day

To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000071776

Disclaimer: Curated by HT Syndication.